Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Tai

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Nature Communications|January 19, 2019
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virusMike Flint, Payel Chatterjee, David L Lin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 22, 2023
STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applicationsCheng Xu, Hannah E Dobson, Mengjie Yu, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2021
Identification of ACE2 modifiers by CRISPR screeningEmily J Sherman, Carmen Mirabelli, Vi T Tang, et al.
Journal of Hepatology|September 6, 2011
A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virusHong Zhao, Wenyu Lin, Kattareeya Kumthip, et al.
Plos Pathogens|March 1, 2022
Identification of cell type specific ACE2 modifiers by CRISPR screeningEmily J Sherman, Carmen Mirabelli, Vi T Tang, et al.
Microbiology Spectrum|September 1, 2021
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing AntibodiesCharles F Schuler, Carmen Gherasim, Kelly O'Shea, et al.
ACS Nano|April 3, 2024
Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine ApplicationsXiaoqi Sun, Xuehui Huang, Kyung Soo Park, et al.
Cell Chemical Biology|June 25, 2021
Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesisJennifer M Zupancic, Alec A Desai, John S Schardt, et al.
Journal of Virology|November 17, 2023
Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infectionJuliana Bragazzi Cunha, Kyle Leix, Emily J Sherman, et al.
Science Advances|November 26, 2021
Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structuresMartina Zafferani, Christina Haddad, Le Luo, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Nature Communications|January 19, 2019
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virusMike Flint, Payel Chatterjee, David L Lin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 22, 2023
STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applicationsCheng Xu, Hannah E Dobson, Mengjie Yu, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2021
Identification of ACE2 modifiers by CRISPR screeningEmily J Sherman, Carmen Mirabelli, Vi T Tang, et al.
Journal of Hepatology|September 6, 2011
A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virusHong Zhao, Wenyu Lin, Kattareeya Kumthip, et al.
Plos Pathogens|March 1, 2022
Identification of cell type specific ACE2 modifiers by CRISPR screeningEmily J Sherman, Carmen Mirabelli, Vi T Tang, et al.
Microbiology Spectrum|September 1, 2021
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing AntibodiesCharles F Schuler, Carmen Gherasim, Kelly O'Shea, et al.
ACS Nano|April 3, 2024
Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine ApplicationsXiaoqi Sun, Xuehui Huang, Kyung Soo Park, et al.
Cell Chemical Biology|June 25, 2021
Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesisJennifer M Zupancic, Alec A Desai, John S Schardt, et al.
Journal of Virology|November 17, 2023
Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infectionJuliana Bragazzi Cunha, Kyle Leix, Emily J Sherman, et al.
Science Advances|November 26, 2021
Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structuresMartina Zafferani, Christina Haddad, Le Luo, et al.
Pageof 6